deltatrials
Completed NA NCT00669032

Efficacy and Safety of Repeated Intraarticular Injections of Hyaluronic Acid in Patients With OA of the Knee

Random, Phase IV, Multicentre, Double Blind, Placebo Controlled, Parallel Study to Assess Long-term Efficacy and Safety of Repeated Intraarticular Injections of Hyaluronic Acid (ADANT®) in Patients With Knee OA of the Knee

Sponsor: Tedec-Meiji Farma, S.A.

Conditions Osteoarthritis of the Knee
Interventions Hyaluronic acid Placebo
Updated 7 times since 2017 Last updated: Aug 2, 2023 Started: Oct 31, 2003 Primary completion: Jul 31, 2009 Completion: Dec 31, 2009

Listed as NCT00669032, this NA trial focuses on Osteoarthritis of the Knee and remains completed. Sponsored by Tedec-Meiji Farma, S.A., it has been updated 7 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Sep 2023 — Jul 2024 [monthly]

    Completed NA

    Phase: PHASE4 → NA

  4. Dec 2021 — Sep 2023 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE4

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Tedec-Meiji Farma, S.A.
Data source: Tedec-Meiji Farma, S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.